The new #PulmonaryArterialHypertension therapy sotatercept, which could be approved for use next year, has produced further positive results in its latest clinical trial. We spoke to Dr Mark Toshner, PH Specialist and Associate Professor, to get the facts about this promising drug - which is the first to target the root cause of the disease.
Негізгі бет What you need to know about new PAH therapy sotatercept
No video
Пікірлер: 10